Blurton; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blurton; Peter.The latest application filed is for "piperazine derivatives for treatment of ad and related conditions".

Company Profile

0.7.8

Blurton; Peter - Welwyn Garden City GB
Blurton; Peter - Hitchin GB
Blurton; Peter - Welwyn Garden GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Piperazine Derivatives For Treatment Of Ad And Related Conditions App 20100204230 - Blurton; Peter ; et al.	2010-08-12
Substituted Piperidines Having Protein Kinase Inhibiting Activity App 20100093748 - Woodhead; Steven John ; et al.	2010-04-15
Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease App 20080300261 - Blurton; Peter ; et al.	2008-12-04
Amino-heterocycles as VR-1 antagonists for treating pain Grant 7,442,701 - Blurton , et al. October 28, 2	2008-10-28
Substituted-1-phthalazinamines as vr-1 antagonists Grant 7,329,659 - Blurton , et al. February 12, 2	2008-02-12
Phenylpyridazine derivatives as ligands for gaba receptors App 20060235021 - Blackaby; Wesley ; et al.	2006-10-19
Substituted-1-phthalazinamines as vr-1 antagonists App 20060229307 - Blurton; Peter ; et al.	2006-10-12
Amino-heterocycles as vr-1 antagonists for treating pain App 20060040947 - Blurton; Peter ; et al.	2006-02-23
Imidazo-triazine derivatives as ligands for GABA receptors Grant 6,936,608 - Bettati , et al. August 30, 2	2005-08-30
Phenylsulphonyl derivatives as 5-HT receptor ligands Grant 6,777,430 - Blurton , et al. August 17, 2	2004-08-17
Imidazo-triazine derivatives as ligands for gaba receptors App 20040023964 - Bettati, Michela ; et al.	2004-02-05
Phenylsulphonyl derivatives as 5-HT receptor ligands App 20030203889 - Blurton, Peter ; et al.	2003-10-30
Pyrrolocinnolines for use as inhibitors of gastric acid secretion Grant 4,988,695 - Brown , et al. January 29, 1	1991-01-29
Intermediates for 3-amino-1,2,5-thiadiazole-1-oxides Grant 4,732,980 - Brown , et al. March 22, 1	1988-03-22
1,2,5-thiadiazol-3,4-diamines Grant 4,663,331 - Brown , et al. May 5, 1	1987-05-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.